Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting

Author： Van Belle Simon JP   Cocquyt Veronique  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.18, 2008-12, pp. : 3261-3270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fosaprepitant (MK-0517): a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting

By Navari Rudolph M  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1977-1985

Informa Healthcare

Access to resources Recommend Favorite

Prevention of chemotherapy induced nausea and vomiting: a focus on aprepitant

By Sankhala Kamalesh K   Pandya Devesh M   Sarantopoulos John   Soefje Scott A   Giles Francis J   Chawla Sant P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1607-1614

Informa Healthcare

Access to resources Recommend Favorite

Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting

By Herrstedt Jørn  

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 231-248

Informa Healthcare

Access to resources Recommend Favorite

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

By Ruhlmann Christina H   Herrstedt Jøørn  

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 449-462

Informa Healthcare

Access to resources Recommend Favorite

Aprepitant: A Review of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Dando T.M.   Perry C.M.  

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 777-794

Adis International

Access to resources Recommend Favorite